Arachidonic acid inhibition of L-type calcium (CaV1.3b) channels varies with accessory CaVbeta subunits
Mandy L Roberts-Crowley1, Ann R Rittenhouse
1Department of Physiology and Program in Neuroscience, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Abstract:
Arachidonic acid (AA) inhibits the activity of several different voltage-gated Ca(2+) channels by an unknown mechanism at an unknown site. The Ca(2+) channel pore-forming subunit (Ca(V)alpha(1)) is a candidate for the site of AA inhibition because T-type Ca(2+) channels, which do not require accessory subunits for expression, are inhibited by AA. Here, we report the unanticipated role of accessory Ca(V)beta subunits on the inhibition of Ca(V)1.3b L-type (L-) current by AA. Whole cell Ba(2+) currents were measured from recombinant channels expressed in human embryonic kidney 293 cells at a test potential of -10 mV from a holding potential of -90 mV. A one-minute exposure to 10 microM AA inhibited currents with beta(1b), beta(3), or beta(4) 58, 51, or 44%, respectively, but with beta(2a) only 31%. At a more depolarized holding potential of -60 mV, currents were inhibited to a lesser degree. These data are best explained by a simple model where AA stabilizes Ca(V)1.3b in a deep closed-channel conformation, resulting in current inhibition. Consistent with this hypothesis, inhibition by AA occurred in the absence of test pulses, indicating that channels do not need to open to become inhibited. AA had no effect on the voltage dependence of holding potential-dependent inactivation or on recovery from inactivation regardless of Ca(V)beta subunit. Unexpectedly, kinetic analysis revealed evidence for two populations of L-channels that exhibit willing and reluctant gating previously described for Ca(V)2 channels. AA preferentially inhibited reluctant gating channels, revealing the accelerated kinetics of willing channels. Additionally, we discovered that the palmitoyl groups of beta(2a) interfere with inhibition by AA. Our novel findings that the Ca(V)beta subunit alters kinetic changes and magnitude of inhibition by AA suggest that Ca(V)beta expression may regulate how AA modulates Ca(2+)-dependent processes that rely on L-channels, such as gene expression, enzyme activation, secretion, and membrane excitability.
Insights
Arachidonic acid (AA) inhibits L-type calcium channels, with accessory Ca(V)beta subunits altering inhibition magnitude. Palmitoylation of Ca(V)beta2a specifically interferes with AA
Area of Science:
- Molecular biology
- Neuroscience
- Cardiovascular research
Background:
- Arachidonic acid (AA) is known to inhibit voltage-gated Ca(2+) channels via an unknown mechanism.
- The pore-forming subunit (Ca(V)alpha(1)) was a candidate site, as T-type channels lacking accessory subunits are inhibited by AA.
Purpose of the Study:
- To investigate the role of accessory Ca(V)beta subunits in AA inhibition of Ca(V)1.3b L-type calcium channels.
- To elucidate the mechanism and site of AA inhibition on L-type calcium currents.
Main Methods:
- Whole-cell patch-clamp electrophysiology was used to measure Ba(2+) currents in recombinant Ca(V)1.3b channels expressed in HEK293 cells.
- The effect of 10 microM AA on currents was assessed with varying Ca(V)beta subunits (beta(1b), beta(2a), beta(3), beta(4)) and holding potentials.
- Kinetic analysis and assessment of inactivation properties were performed.
Main Results:
- AA inhibited Ca(V)1.3b currents, with inhibition magnitude varying significantly with different Ca(V)beta subunits (e.g., 58% with beta(1b) vs. 31% with beta(2a)).
- AA preferentially inhibited reluctant gating channels, suggesting stabilization of a deep closed-channel conformation.
- Palmitoyl groups on beta(2a) were found to interfere with AA inhibition.
Conclusions:
- Ca(V)beta subunits critically modulate the extent and kinetics of AA inhibition on Ca(V)1.3b channels.
- AA-induced inhibition occurs independently of channel opening, stabilizing a closed state.
- Ca(V)beta expression may be a key regulator of AA's impact on Ca(2+)-dependent cellular processes.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
G-Protein Gated Ion Channels
Sensory organs,...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...


